Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgad563 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Nesrin Damla Karakaplan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Research Unit, Division of Endocrinology, Diabetes and Nutrition, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Hyperinsulinism, Insulin Resistance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDDK NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Context
The impact of insulin, particularly exogenous hyperinsulinemia, on insulin secretion in humans is debated.
Objective
We assessed the effects of exogenous hyperinsulinemia on insulin secretion and whether the response is altered in insulin resistance associated with obesity.
Methods
Insulin secretion rates (ISRs) during euglycemic hyperinsulinemic clamp studies (52 volunteers) were calculated using a model that employs plasma C-peptide concentrations. One study involved a 2-step insulin clamp and the other study was a single step insulin clamp. For both studies the goal was to achieve plasma glucose concentrations of 95 mg/dL during the clamp irrespective of fasting glucose concentrations. The percent change in ISR from fasting to the end of the insulin clamp interval was the main outcome. Linear regression and analysis of covariance were used to test for the effects of insulin on ISR and to test for group differences.
Results
ISR was greater in obese volunteers (P < .001) under fasting and hyperinsulinemic clamp conditions. The change in plasma glucose from baseline to the end of the insulin clamp interval was highly correlated with the change in ISR (r = 0.61, P < .001). From baseline to the end of the clamp we observed a 27% (SD 20) suppression of ISR. The participants who underwent a 2-step insulin clamp had greater suppression of ISR during the second step than the first step (P < .001). The proportional suppression of ISR during euglycemic hyperinsulinemia was not different between nonobese and obese groups (P = .19).
Conclusion
Hyperinsulinemia suppresses endogenous insulin secretion and the relative change in insulin secretion produced by exogenous insulin did not differ between nonobese and obese people.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrine Research Unit, Division of Endocrinology, Diabetes and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Nesrin Damla Karakaplan, Yilin Song, Marcello C Laurenti, Adrian Vella, Michael D Jensen
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- National Institute of Health
Zitieren
APA
Karakaplan, N. D., Song, Y., Laurenti, M. C., Vella, A., & Jensen, M. D. (2024). Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad563
Vancouver
Karakaplan ND, Song Y, Laurenti MC, Vella A, Jensen MD. Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad563
BibTeX
@article{Karakaplan2024,
author = {Karakaplan, Nesrin Damla and Song, Yilin and Laurenti, Marcello C and Vella, Adrian and Jensen, Michael D},
title = {Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgad563}
}
EUVIMED